-
Product Insights
Pink Trial Solar Energy Center
Pink Trial Solar Energy Center is a solar PV project located in Florida, United States. The project is owned and developed by Florida Power & Light Co. The project came online in 2023. Empower your strategies with our Pink Trial Solar Energy Center report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval Analysis for Eye Infections
Overview How likely is it that the drugs in Eye Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eye Infections Overview An eye infection is a disease caused by a...
-
Product Insights
NewLikelihood of Approval Analysis for Prurigo
Overview How likely is it that the drugs in Prurigo will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prurigo Overview Prurigo nodularis (PN) is a skin disease characterized by pruritic (itchy)...
-
Product Insights
NewLikelihood of Approval Analysis for Actinic (Solar) Keratosis
Overview How likely is it that the drugs in Actinic (Solar) Keratosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Actinic (Solar) Keratosis Overview An actinic keratosis, also known as a...
-
Product Insights
NewLikelihood of Approval Analysis for Conjunctivitis
Overview How likely is it that the drugs in Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Conjunctivitis Overview Conjunctivitis, commonly known as "pink eye", refers to inflammation of the...
-
Product Insights
NewLikelihood of Approval Analysis for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
Overview How likely is it that the drugs in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) Overview Systemic-onset...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ranpirnase in Viral Conjunctivitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ranpirnase in Viral Conjunctivitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ranpirnase in Viral Conjunctivitis Drug Details: Ranpirnase (OKG-0301) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povidone Iodine ER in Viral Conjunctivitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povidone Iodine ER in Viral Conjunctivitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povidone Iodine ER in Viral Conjunctivitis Drug Details: Povidone iodine...
-
Sector Analysis
Asia-Pacific (APAC) Household Products Market Opportunities, Trends, Growth Analysis and Forecast to 2027
APAC Household Products Market Report Overview The APAC household products market size was estimated at $104.9 billion in 2022 and is likely to grow at a CAGR of more than 3% from 2022 to 2027. Tissue & hygiene was the largest category in the APAC household products sector in 2022. APAC Household Products Market Outlook 2022-2027 ($ Billion) Buy the Full Report for APAC Household Products Market Forecasts Download a Free Sample Report The APAC Household Products market research report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povidone Iodine Er in Viral Conjunctivitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Povidone Iodine Er in Viral ConjunctivitisDrug Details:Povidone iodine is under development for the treatment of acute...